Global Intrathecal Pumps Market by Type (Bupivacaine, Morphine), by Application (Spasticity, Pain) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global intrathecal pumps market value was USD 189.7 Million in 2020. It is expected to grow at a compound anual growth rate (CAGR of 5.1%) between 2021 and 2028. Due to rising cancer rates and other chronic pain conditions, there is a growing demand for these products. Market growth is also influenced by the aging population, as well as the elimination or reduction of pain medication. Chronic pain is the leading cause of disability. It is also linked to high social and economic burdens. According to the National Cancer Institute (NCI), the annual rate of new cases of cancer is 442.4 per 100,000 people. Because they are directly in the CSF, intrathecal pumps can be more effective than oral medication. Drugs can be absorbed faster and more directly.

They also require less medication than oral medications. The amount of medication required for pain pumps is approximately 1/300 that of oral medications. The market is expected to grow due to technological advances such as the ability to pump drugs to the most common places, increased potency, lower systemic exposure and the dose necessary to achieve the desired pharmacologic effect. Flowonix Medicals has introduced a 40 mL pump for the administration of drugs into the intrathecal spaces. The delivery device is a pressure-driven, valve-gated delivery mechanism that can last more than 10 years. This could help to reduce the need for future surgical procedures.

The intrathecal pump allows for medication or drug delivery. This can improve comfort and ease chronic pain. It also reduces the need to take painkillers. Patients can resume their lives. Intrathecal drug delivery can be used to treat pain related to conditions such as unsuccessful spine or neck surgeries, chronic pain, neck pain, abdominal pain, and other problems. It also aids in the treatment of spasticity (muscle rigidity, spasms and other conditions). The U.S. Food and Drug Administration has yet to approve all intrathecal pump usage. The FDA has warned healthcare professionals and patients about the potential dangers of using drugs that haven't been approved by it. Additional safety requirements must be met for drugs that have been approved for intrathecal use. Market growth may be impeded by potential risks such as dosing errors, infections, pump failure, opioid withdrawal, or other issues like muscle spasms and cognitive changes, pain and fever, vomiting, weakness, heart disease, or heart attack.

Pain is a clinically important condition in the elderly. It is difficult to evaluate pain in elderly patients due to the many complications that can be caused by a variety of comorbidities. However, intrathecal pumps have shown better results in pain management for geriatric patients. The product demand is growing due to the increasing geriatric population. According to the WHO, the global population of 60-year-olds and older is expected to rise from 900 million people in 2015 to 2 billion by 2050.

Due to the COVID-19 pandemic, healthcare has been faced with extraordinary challenges. Because most chronic pain services were non-urgent, elective outpatient and interventional procedures were stopped or limited during the pandemic in order to lower the risk of infection. Patients with chronic pain who were using an intrathecal pump and missed refills or replacement sessions had to take a significant risk, and most cases had to be sustained by oral medication, which hindered market growth. The market will continue to grow as all services are resumed.

Type Insights

The market can be divided into several types: morphine (ziconotide), clonidine (bupivacaine), clonidine (clonidine), clonidine and clonidine) and baclofen (bupivacaine). In 2020, the morphine segment was responsible for 31% of all revenue. Intrachecal morphine administration is one the most effective treatments for severe chronic pain. It is often used as part of a long-term care plan. Opioids are considered the "gold standard" in postoperative pain management. With morphine being the most frequently used opioids in clinical settings, it is expected that it will drive the segment's growth.

The fastest expected CAGR for the bupivacaine market segment will be during the forecast period. Its widespread use in pain management post-operatively is a contributing factor to its growth. Bupivacaine administration provides better pain relief than epidural. It is more effective intrathecal. Clonidine is expected to continue growing at a rapid pace. Both cancer and non-cancer pain have been helped by intrathecal clonidine.

Application Insights

In 2020, the pain segment accounted for more than 70% of all revenue. This segment is expected to grow at a 5.4% CAGR between 2021 and 2028. Chronic pain is a common component of chronic diseases such as cancer. However, chronic pain is becoming a distinct health concern that can have severe consequences for patients. The School of Public Health at Boston University estimates that chronic pain affects approximately 1.5 billion people worldwide. Its prevalence increases with age. According to the CDC, chronic pain is affecting approximately 50 million Americans, with high-impact chronic pain affecting about 20 million.

From 2021 to 2028, spasticity is expected to increase at a 4.6% CAGR. According to the American Association of Neurological Surgeons (AANS), more than 12,000,000 people are affected by spasticity worldwide. Common conditions such as Traumatic Brain Injury, Cerebral Palsy, Spinal Cord Injury, Multiple Sclerosis (MS), Multiple Sclerosis (MS) and stroke account for most of this population. Due to the introductions of new spasticity products, the market will grow. Flowonix Medical, for example, has introduced the Prometra II Programmable Pump System. This can be used with intrathecal Baclofen to treat spasticity under a number of conditions including multiple sclerosis.

Regional Insights

North America was the dominant market, accounting for over 40% of the total revenue in 2020. Market growth is expected to be driven by the high incidence of cancer and related conditions such as chronic back or neck pain. According to the CDC, 50 million Americans suffer from chronic pain. Patient outcomes and safety are also of paramount importance. Various projects have been set up to improve healthcare quality at an affordable price in the U.S. North America has a higher healthcare spending than any other country, which contributes to its growth.

The market in Asia Pacific is expected to experience the fastest CAGR at 6.9% over the forecast period. The COVID-19 epidemic has brought to light the regional's failings and flaws in its health system, as well the interdependence between economic stability and health security. The region is now moving closer to achieving Universal Health Care (UHC). The APAC region's growing geriatric population, as well as changing lifestyles, will likely boost market growth.

Market Share Insights & Key Companies

The market is highly competitive because of the large number of local and global manufacturers. Major companies have a variety of growth strategies to gain a large share of this market. These include new product development, product differentiation, financing, and international strategy. In January 2021, Flowonix Medical (a U.S.-based medical device company that focuses on implantable, advanced drug delivery systems), received $33,000,000 in grants. SWK Holdings, a specialist finance firm that assists small and medium-sized life-science companies in the commercial stage, provided a $10m debt facility. These are the top players in the global intrathecal pump market:

• Tricumed Medizintechnik GmbH

• Codman and Shurtleff

• Teleflex, Inc.

• Flowonix Medical, Inc.

• Zimmer Biomet

• Medtronic

Up Market Research published a new report titled “Intrathecal Pumps Market research report which is segmented by Type (Bupivacaine, Morphine), by Application (Spasticity, Pain), By Players/Companies Codman and Shurtleff, Teleflex Incorporated, Zimmer Biomet, Tricumed Medizintechnik GmbH, Medtronic, FLOWONIX MEDICAL INC”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Intrathecal Pumps Market Report Segments:

The market is segmented by Type (Bupivacaine, Morphine), by Application (Spasticity, Pain).

Intrathecal Pumps Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Intrathecal Pumps Market

Overview of the regional outlook of the Intrathecal Pumps Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Intrathecal Pumps Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Intrathecal Pumps Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Bupivacaine

                2. Morphine

                1. Spasticity

                2. Pain

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intrathecal Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Intrathecal Pumps Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.